This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cadarette, S. M.
Right arrow Articles by Tu, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cadarette, S. M.
Right arrow Articles by Tu, J. V.
Related Collections
Right arrow Radiological diagnosis
Right arrow Osteoporosis
Right arrow Menopause (including HRT)
CMAJ • May 2, 2000; 162 (9)
© 2000 Canadian Medical Association or its licensors

Research
Recherche

Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry

Suzanne M. Cadarette*{dagger}{ddagger}, Susan B. Jaglal*{dagger}§¶**, Nancy Kreiger*{dagger}{dagger}{dagger}, Warren J. McIsaac{ddagger}{ddagger}, Gerarda A. Darlington{ddagger}§§ and Jack V. Tu{dagger}¶**¶¶

From *the Canadian Multicentre Osteoporosis Study; {dagger}the Department of Public Health Sciences, University of Toronto, Toronto, Ont.; {ddagger}Population Health Sciences, Research Institute, Hospital for Sick Children, Toronto, Ont.; §the Department of Rehabilitation Science, University of Toronto; ¶the Institute for Clinical and Evaluative Sciences, Toronto, Ont.; **the Sunnybrook & Women's College Health Sciences Centre, Toronto, Ont.; {dagger}{dagger}the Division of Preventive Oncology, Cancer Care Ontario, Toronto, Ont.; and {ddagger}{ddagger}the Mount Sinai Family Medicine Centre, Department of Family and Community Medicine, §§the Faculty of Nursing and ¶¶the Department of Medicine, University of Toronto

Background: Although mass screening for osteoporosis is not recommended among postmenopausal women, there is no consensus on which women should undergo testing for low bone mineral density. The objective of this study was to develop and validate a clinical tool to help clinicians identify which women are at increased risk for osteoporosis and should therefore undergo further testing with bone densitometry.

Methods: Using Ontario baseline data from the Canadian Multicentre Osteoporosis Study, we identified all cognitively normal women aged 45 years or more who had undergone testing with dual-energy x-ray absorptiometry (DXA) at both the femoral neck and the lumbar spine (L1-L4). Participants who had a previous diagnosis of osteoporosis or were taking bone active medication other than ovarian hormones were excluded. The main outcome measure was low bone mineral density (T score of 2 or more standard deviations below the mean for young Canadian women) at either the femoral neck or the lumbar spine. Logistic regression analysis and receiver operating characteristic (ROC) analysis were used to identify the simplest algorithm that would identify women at increased risk for low bone mineral density.

Results: The study population comprised 1376 women, of whom 926 were allocated to the development of the tool and 450 to its validation. A simple algorithm based on age, weight and current estrogen use (yes or no) was developed. Validation of this 3-item Osteoporosis Risk Assessment Instrument (ORAI) showed that the tool had a sensitivity of 93.3% (95% confidence interval [CI] 86.3%-97.0%) and a specificity of 46.4% (95% CI 41.0%-51.8%) for selecting women with low bone mineral density. The sensitivity of the instrument for selecting women with osteoporosis was 94.4% (95% CI 83.7%-98.6%). Use of the ORAI represented a 38.7% reduction in DXA testing compared with screening all women in our study.

Interpretation: The ORAI accurately identifies the vast majority of women likely to have low bone mineral density and is effective in substantially decreasing the need for all women to undergo DXA testing.




This article has been cited by other articles:


Home page
 QJMHome page
A. El Maghraoui and C. Roux
DXA scanning in clinical practice
QJM, August 1, 2008; 101(8): 605 - 617.
[Abstract] [Full Text] [PDF]

Home page
 Dentomaxillofac RadiolHome page
T Nakamoto, A Taguchi, M Ohtsuka, Y Suei, M Fujita, M Tsuda, M Sanada, Y Kudo, A Asano, and K Tanimoto
A computer-aided diagnosis system to screen for osteoporosis using dental panoramic radiographs
Dentomaxillofac. Radiol., July 1, 2008; 37(5): 274 - 281.
[Abstract] [Full Text] [PDF]

Home page
 Dentomaxillofac RadiolHome page
O Nackaerts, R Jacobs, H Devlin, S Pavitt, E Bleyen, B Yan, H Borghs, C Lindh, K Karayianni, P van der Stelt, et al.
Osteoporosis detection using intraoral densitometry
Dentomaxillofac. Radiol., July 1, 2008; 37(5): 282 - 287.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
I. Guessous, J. Cornuz, C. Ruffieux, P. Burckhardt, and M.-A. Krieg
Osteoporotic Fracture Risk in Elderly Women: Estimation with Quantitative Heel US and Clinical Risk Factors
Radiology, July 1, 2008; 248(1): 179 - 184.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Perrini, A. Natalicchio, L. Laviola, A. Cignarelli, M. Melchiorre, F. De Stefano, C. Caccioppoli, A. Leonardini, S. Martemucci, G. Belsanti, et al.
Abnormalities of Insulin-Like Growth Factor-I Signaling and Impaired Cell Proliferation in Osteoblasts from Subjects with Osteoporosis
Endocrinology, March 1, 2008; 149(3): 1302 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
E. J. MacLaughlin and C. L. Raehl
ASHP Therapeutic Position Statement on the Prevention and Treatment of Osteoporosis in Adults
Am. J. Health Syst. Pharm., February 15, 2008; 65(4): 343 - 357.
[Full Text] [PDF]

Home page
 Am J EpidemiolHome page
M. A. Brookhart, A. R. Patrick, C. Dormuth, J. Avorn, W. Shrank, S. M. Cadarette, and D. H. Solomon
Adherence to Lipid-lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect
Am. J. Epidemiol., August 1, 2007; 166(3): 348 - 354.
[Abstract] [Full Text] [PDF]

Home page
 J Gerontol A Biol Sci Med SciHome page
C. M. Boyd, C. O. Weiss, J. Halter, K. C. Han, W. B. Ershler, and L. P. Fried
Framework for Evaluating Disease Severity Measures in Older Adults With Comorbidity
J Gerontol A Biol Sci Med Sci, March 1, 2007; 62(3): 286 - 295.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
T.P. van Staa, P. Geusens, J.A. Kanis, H.G.M. Leufkens, S. Gehlbach, and C. Cooper
A simple clinical score for estimating the long-term risk of fracture in post-menopausal women
QJM, October 1, 2006; 99(10): 673 - 682.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Med.Home page
O. Johnell
Review: no single physical examination sign rules in or out osteoporosis or spinal fracture
Evid. Based Med., August 1, 2005; 10(4): 123 - 123.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
K. F. Mauck, M.-T. Cuddihy, E. J. Atkinson, and L. J. Melton III
Use of Clinical Prediction Rules in Detecting Osteoporosis in a Population-Based Sample of Postmenopausal Women
Arch Intern Med, March 14, 2005; 165(5): 530 - 536.
[Abstract] [Full Text] [PDF]

Home page
 Chronic Respiratory DiseaseHome page
B J Smith, H J McElroy, L L Laslett, K D Pile, P J Phillips, G Phillipov, S M Evans, J S Weekley, and L S Pilotto
Osteoporosis screening in people with airways disease
Chronic Respiratory Disease, January 1, 2005; 2(1): 5 - 12.
[Abstract] [PDF]

Home page
 JAMAHome page
A. D. Green, C. S. Colon-Emeric, L. Bastian, M. T. Drake, and K. W. Lyles
Does This Woman Have Osteoporosis?
JAMA, December 15, 2004; 292(23): 2890 - 2900.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
A. Taguchi, Y. Suei, M. Sanada, M. Ohtsuka, T. Nakamoto, H. Sumida, K. Ohama, and K. Tanimoto
Validation of Dental Panoramic Radiography Measures for Identifying Postmenopausal Women with Spinal Osteoporosis
Am. J. Roentgenol., December 1, 2004; 183(6): 1755 - 1760.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
F. Richy, F. Deceulaer, O. Ethgen, O. Bruyere, and J.-Y. Reginster
Development and Validation of the ORACLE Score to Predict Risk of Osteoporosis
Mayo Clin. Proc., November 1, 2004; 79(11): 1402 - 1408.
[Abstract] [PDF]

Home page
 QJMHome page
F. Richy, M. Gourlay, P.D. Ross, S.S. Sen, L. Radican, F. De Ceulaer, W. Ben Sedrine, O. Ethgen, O. Bruyere, and J.-Y. Reginster
Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium
QJM, January 1, 2004; 97(1): 39 - 46.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
J. P. Brown and R. G. Josse
Lignes directrices de pratique clinique 2002 pour le diagnostic et le traitement de l'osteoporose au Canada
Can. Med. Assoc. J., March 18, 2003; 168(90060): SF1 - 38.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
G Haugeberg, R E Orstavik, T Uhlig, J A Falch, J I Halse, and T K Kvien
Clinical decision rules in rheumatoid arthritis: do they identify patients at high risk for osteoporosis? Testing clinical criteria in a population based cohort of patients with rheumatoid arthritis recruited from the Oslo Rheumatoid Arthritis Register
Ann Rheum Dis, December 1, 2002; 61(12): 1085 - 1089.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
J. P. Brown and R. G. Josse
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada
Can. Med. Assoc. J., November 12, 2002; 167(90100): s1 - 34.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
U.S. Preventive Services Task Force*
Screening for Osteoporosis in Postmenopausal Women: Recommendations and Rationale
Ann Intern Med, September 17, 2002; 137(6): 526 - 528.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
H. D. Nelson, M. Helfand, S. H. Woolf, and J. D. Allan
Screening for Postmenopausal Osteoporosis: A Review of the Evidence for the U.S. Preventive Services Task Force
Ann Intern Med, September 17, 2002; 137(6): 529 - 541.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
K. A. Kovacs
Decision rules for bone mineral density testing
Can. Med. Assoc. J., September 1, 2002; 167(5): 509 - 509.
[Full Text]

Home page
 Mayo Clin Proc.Home page
W. B. Sedrine and J.-Y. Reginster
Risk Indices and Osteoporosis Screening: Scope and Limits
Mayo Clin. Proc., July 1, 2002; 77(7): 622 - 623.
[PDF]

Home page
 Mayo Clin Proc.Home page
P. Geusens, M. C. Hochberg, D. J. M. van der Voort, H. Pols, M. van der Klift, E. Siris, M. E. Melton, J. Turpin, C. Byrnes, and P. D. Ross
Performance of Risk Indices for Identifying Low Bone Density in Postmenopausal Women
Mayo Clin. Proc., July 1, 2002; 77(7): 629 - 637.
[Abstract] [PDF]

Home page
 JAMAHome page
S. M. Cadarette, S. B. Jaglal, T. M. Murray, W. J. McIsaac, L. Joseph, J. P. Brown, and for the Canadian Multicentre Osteoporosis Study
Evaluation of Decision Rules for Referring Women for Bone Densitometry by Dual-Energy X-ray Absorptiometry
JAMA, July 4, 2001; 286(1): 57 - 63.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Med.Home page
J.-Y. Reginster
A simple clinical tool that included age, weight, and oestrogen use helped to select women for bone densitometry
Evid. Based Med., January 1, 2001; 6(1): 32 - 32.
[Full Text]